Statistics for Development of a Novel STAT3 Inhibitor for the Treatment and Chemoprevention of Lung Cancer

Total visits

views
Development of a Novel STAT3 Inhibitor for the Treatment and Chemoprevention of Lung Cancer 215

Total visits per month

views
August 2024 0
September 2024 1
October 2024 0
November 2024 0
December 2024 0
January 2025 0
February 2025 0

File Visits

views
Njatcha_umn_0130E_19968.pdf 237

Top country views

views
China 75
United States 73
India 10
Egypt 6
Hong Kong SAR China 5
United Kingdom 3
Hungary 3
South Korea 3
Sweden 3
Taiwan 3
Australia 2
Canada 2
Germany 2
Ireland 2
Singapore 2
Austria 1
Belgium 1
Algeria 1
Spain 1
Greece 1
Indonesia 1
Israel 1
Italy 1
Poland 1
Russia 1
Saudi Arabia 1

Top city views

views
Dallas 11
Beijing 9
Hangzhou 9
Minneapolis 7
Miami 5
Shanghai 5
Bengaluru 4
Ashburn 3
Budapest 3
Des Moines 3
Taizhou 3
Zhengzhou 3
Chicago 2
Dublin 2
Geelong 2
Las Vegas 2
Pittsburgh 2
Putian 2
Rochester 2
San Francisco 2
San Jose 2
Singapore 2
St Louis 2
Taipei 2
Washington 2
Wuhan 2
Xiulin 2
Xuzhou 2
Yaocheng 2
Ajmer 1
Al Fayyum 1
Albuquerque 1
Alexandria 1
Athens 1
Auburn 1
Barcelona 1
Bharatpur 1
Boardman 1
Bunkyo-ku 1
Busan 1
Cairo 1
Central 1
Chongqing 1
Daegu 1
Dongguan 1
Duarte 1
Edmond 1
Elizabethtown 1
Gaithersburg 1
Glen Burnie 1
Greenwich 1
Gurgaon 1
Haifa 1
Handan 1
Huizhou 1
Huzhou 1
Indianapolis 1
Jinhu 1
Kaifeng 1
Kielce 1
Kitchener 1
Kolkata 1
La Junta 1
Laiwu 1
Leipzig 1
Leuven 1
Lexington 1
Los Angeles 1
Milan 1
Montreal 1
Morton Grove 1
Newcastle upon Tyne 1
Norsborg 1
Oakland 1
Old Bridge 1
Osaka 1
Pullman 1
Quanzhou 1
San Diego 1
Seongbuk-gu 1
Setagaya-ku 1
Shimotoda 1
Spring Valley 1
Stockholm 1
Tongxiang 1
Vienna 1
Vladivostok 1
Waukesha 1
Wenzhou 1
Westland 1
Yamanashi 1
Yangzhou 1